Boston Scientific Corporation (0HOY.L)
USD 89.2
(-1.53%)
USD 89.2
(-1.53%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 9.09 Billion USD | 3.08% |
| 2022 | 9.28 Billion USD | -2.55% |
| 2021 | 9.52 Billion USD | -0.93% |
| 2020 | 9.61 Billion USD | -7.12% |
| 2019 | 10.35 Billion USD | 46.7% |
| 2018 | 7.05 Billion USD | 25.64% |
| 2017 | 5.61 Billion USD | 2.41% |
| 2016 | 5.48 Billion USD | -3.4% |
| 2015 | 5.67 Billion USD | 33.77% |
| 2014 | 4.24 Billion USD | -0.09% |
| 2013 | 4.24 Billion USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 11 Billion USD | 15.9% |
| 2024 Q2 | 10.56 Billion USD | -3.95% |
| 2024 Q3 | 10.88 Billion USD | 2.97% |
| 2023 FY | 9.49 Billion USD | 2.26% |
| 2023 Q4 | 9.49 Billion USD | 2.08% |
| 2023 Q2 | 9.45 Billion USD | 0.95% |
| 2023 Q3 | 9.29 Billion USD | -1.64% |
| 2023 Q1 | 9.36 Billion USD | 0.89% |
| 2022 Q4 | 9.28 Billion USD | 3.9% |
| 2022 Q2 | 9.32 Billion USD | -3.66% |
| 2022 Q1 | 9.68 Billion USD | 1.66% |
| 2022 FY | 9.28 Billion USD | -2.55% |
| 2022 Q3 | 8.93 Billion USD | -4.23% |
| 2021 Q2 | 9.46 Billion USD | 0.21% |
| 2021 Q4 | 9.52 Billion USD | 0.67% |
| 2021 FY | 9.52 Billion USD | -0.93% |
| 2021 Q3 | 9.46 Billion USD | -0.06% |
| 2021 Q1 | 9.44 Billion USD | -1.01% |
| 2020 FY | 9.61 Billion USD | -7.12% |
| 2020 Q1 | 10.6 Billion USD | 3.11% |
| 2020 Q2 | 9.79 Billion USD | -7.63% |
| 2020 Q4 | 9.54 Billion USD | -0.5% |
| 2020 Q3 | 9.59 Billion USD | -2.07% |
| 2019 Q3 | 11.13 Billion USD | 14.29% |
| 2019 Q2 | 9.74 Billion USD | 3.24% |
| 2019 FY | 10.35 Billion USD | 46.7% |
| 2019 Q1 | 9.43 Billion USD | 32.94% |
| 2019 Q4 | 10.28 Billion USD | -7.67% |
| 2018 Q2 | 6.49 Billion USD | 12.63% |
| 2018 Q1 | 5.76 Billion USD | 2.65% |
| 2018 FY | 7.05 Billion USD | 25.64% |
| 2018 Q4 | 7.1 Billion USD | 7.15% |
| 2018 Q3 | 6.62 Billion USD | 2.05% |
| 2017 Q4 | 5.61 Billion USD | -1.16% |
| 2017 FY | 5.61 Billion USD | 2.41% |
| 2017 Q2 | 5.83 Billion USD | 5.82% |
| 2017 Q1 | 5.51 Billion USD | 0.55% |
| 2017 Q3 | 5.68 Billion USD | -2.62% |
| 2016 Q1 | 5.67 Billion USD | 0.0% |
| 2016 Q4 | 5.48 Billion USD | 1.09% |
| 2016 Q3 | 5.42 Billion USD | -0.04% |
| 2016 Q2 | 5.42 Billion USD | -4.4% |
| 2016 FY | 5.48 Billion USD | -3.4% |
| 2015 Q2 | 5.11 Billion USD | 19.78% |
| 2015 FY | 5.67 Billion USD | 33.77% |
| 2015 Q4 | 5.67 Billion USD | -3.11% |
| 2015 Q3 | 5.85 Billion USD | 14.61% |
| 2015 Q1 | 4.26 Billion USD | 0.57% |
| 2014 Q2 | 4.25 Billion USD | 0.14% |
| 2014 Q3 | 4.25 Billion USD | -0.07% |
| 2014 Q4 | 4.24 Billion USD | -0.19% |
| 2014 FY | 4.24 Billion USD | -0.09% |
| 2014 Q1 | 4.24 Billion USD | 0.02% |
| 2013 Q2 | 4.25 Billion USD | -0.05% |
| 2013 Q1 | 4.25 Billion USD | 0.0% |
| 2013 FY | 4.24 Billion USD | 0.0% |
| 2013 Q3 | 4.24 Billion USD | -0.07% |
| 2013 Q4 | 4.24 Billion USD | -0.02% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -75815.881% |
| Accuray Incorporated | 172.15 Million USD | -5184.161% |
| Align Technology, Inc. | 96.96 Million USD | -9281.445% |
| Elevance Health Inc. | 25.12 Billion USD | 63.786% |
| AxoGen, Inc. | 69.29 Million USD | -13028.5% |
| CVS Health Corporation | 79.38 Billion USD | 88.541% |
| Cardinal Health, Inc. | 5.6 Billion USD | -62.186% |
| Centene Corporation | 17.69 Billion USD | 48.602% |
| DaVita Inc. | 11.11 Billion USD | 18.166% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 78.268% |
| Hologic, Inc. | 2.53 Billion USD | -258.913% |
| Humana Inc. | 10.21 Billion USD | 10.927% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -859.721% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | -52.783% |
| Masimo Corporation | 970 Million USD | -837.835% |
| McKesson Corporation | 5.47 Billion USD | -66.246% |
| Patterson Companies, Inc. | 762.94 Million USD | -1092.361% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | -69.436% |
| ResMed Inc. | 873.93 Million USD | -940.924% |
| Henry Schein, Inc. | 2.74 Billion USD | -231.886% |
| Teladoc Health, Inc. | 1.59 Billion USD | -471.32% |
| Universal Health Services, Inc. | 5.36 Billion USD | -69.511% |
| Veeva Systems Inc. | 55.77 Million USD | -16210.175% |
| Baxter International Inc. | 14.36 Billion USD | 36.668% |
| Becton, Dickinson and Company | 15.87 Billion USD | 42.71% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -10030.29% |
| Danaher Corporation | 19.35 Billion USD | 53.002% |
| Stryker Corporation | 12.99 Billion USD | 29.996% |
| Medtronic plc | 24.96 Billion USD | 63.558% |